Concord Wealth Partners Amneal Pharmaceuticals, Inc. Transaction History
Concord Wealth Partners
- $603 Million
- Q4 2024
Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
190Shares Held
140MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$192 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$129 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$109 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$99.5 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$94.6 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.34B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...